Detail Page

  • 24002000549998240020001741954575479108968PublicAssets/3326This image shows the structure of the CYP17A1 enzyme (ribbons colored from blue N-terminus to red C-terminus), with the associated heme colored black. The prostate cancer drug abiraterone is colored gray. Cytochrome P450 enzymes bind to and metabolize a variety of chemicals, including drugs. Cytochrome P450 17A1 also helps create steroid hormones. Emily Scott's lab is studying how CYP17A1 could be selectively inhibited to treat prostate cancer. She and graduate student Natasha DeVore elucidated the structure shown using X-ray crystallography. Dr. Scott created the image (both white bg and transparent bg) for the NIGMS image gallery. See the "Medium-Resolution Image" for a PNG version of the image that is transparent.Emily Scott, University of KansasEmily Scott, University of KansasIllustration

    Topic Tags:

    Chemistry, Biochemistry, and PharmacologyMolecular StructuresTools and Techniques

    Cytochrome structure with anticancer drug

    View EntryAdd to My Images

    This image shows the structure of the CYP17A1 enzyme (ribbons colored from blue N-terminus to red C-terminus), with the associated heme colored black. The prostate cancer drug abiraterone is colored gray. Cytochrome P450 enzymes bind to and metabolize a variety of chemicals, including drugs. Cytochrome P450 17A1 also helps create steroid hormones. Emily Scott's lab is studying how CYP17A1 could be selectively inhibited to treat prostate cancer. She and graduate student Natasha DeVore elucidated the structure shown using X-ray crystallography. Dr. Scott created the image (both white bg and transparent bg) for the NIGMS image gallery. See the "Medium-Resolution Image" for a PNG version of the image that is transparent.

    Source

    Emily Scott, University of Kansas

    Credit Line

    Emily Scott, University of Kansas

    Record Type

    Illustration

    ID

    3326

My Images/Videos